Supply of Porcine Factor VIII (Susoctocog Alfa) for Blood Disorders to NHS Scotland
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · Awarded contract
AwardedSupply of Porcine Factor VIII (Susoctocog Alfa) for Blood Disorders to NHS Scotland
Awarded Unknown
About
The Common Services Agency (NHS National Services Scotland) awarded a contract to Takeda UK Limited for the supply of products for the treatment of blood disorders, including Haemophilia A and B, specifically Porcine Factor VIII (suscocog alfa), to NHS Scotland.
The contract value was GBP 1.
Similar open tenders12
TenderCloses
Supply of Nitric Oxide Therapy – NHS ScotlandHealth & Medical
14 Dec 2026
Supply of Vascular Therapy and Associated Products Framework – Acute and Chronic (NHS Supply Chain)Health & Medical
19 Jan 2027
Supply of COVID-19 Vaccines via Dynamic Purchasing System (UKHSA) 2024–2028Health & Medical
24 Sep 2028
Tissue and Cell Management System for Stem Cell Transplantation and Cellular Therapy – King's College HospitalIT & Software
26 Nov 2026
Framework Agreement for General Office Supplies to Scottish Public Sector (2027)Miscellaneous
17 Dec 2026
HIV Prevention, Diagnosis and Support Services – NHS LothianHealth & Medical
07 Dec 2026
National Framework Agreement for Genetic Hearing Loss Testing Solutions – NHS Supply ChainHealth & Medical
30 Nov 2026
Framework Agreement for Supply of Unlicensed Imported Medicines – North East & Yorkshire NHS (NEYPPC)Health & Medical
30 Nov 2026
Supply of External Defibrillators, Consumables and Mechanical Chest Compression Devices – NHS Supply ChainHealth & Medical
10 Dec 2026
NHS Supply Chain Framework for Urology and Bowel Management Devices and ConsumablesHealth & Medical
13 Jan 2027
Medicinal Products Dynamic Purchasing System [131864]Health & Medical
23 Feb 2029
Managed Pathology Service for Gloucestershire Hospitals – Equipment, Reagents, Maintenance & Hub ConsolidationHealth & Medical
04 Dec 2026
Other similar contracts12
Contract and supplierAwarded value
Supply of Standard Half-Life Recombinant Factor VIII for Blood Disorders to NHS ScotlandHealth & MedicalTakeda UK Limited,Pfizer Limited,Octapharma Ltd
$9,070,137
Supply of Enhanced Half-Life Recombinant Factor VIII for Blood Disorders to NHS ScotlandHealth & MedicalNovo Nordisk Ltd,Swedish Orphan Biovitrum Ltd
$7,134,755
Supply of Factor VIII Inhibitor Bypassing Fraction for Blood Disorders to NHS ScotlandHealth & MedicalTakeda UK Limited
$502,964
Supply of Blood Disorder Treatments Including Haemophilia A & B to NHS ScotlandHealth & MedicalTakeda UK Limited,Pfizer Limited
$4,604,830
Supply of Plasma-Derived Factor VIII for Haemophilia A Treatment to NHS National Services ScotlandHealth & MedicalGrifols UK Limited,Biotest (UK) Ltd,Octapharma Ltd,Bio Products Laboratory
$718,000
Supply of Enhanced Half-Life Recombinant Factor VIII for Blood Disorders to NHS ScotlandHealth & MedicalRoche Products Ltd
$40,327,988
Supply of High Purity Factor IX for Blood Disorders to NHS ScotlandHealth & MedicalBio Products Laboratory
$1
Supply of Recombinant Factor VII for Blood Disorders to NHS ScotlandHealth & MedicalNovo Nordisk Ltd,LFB Biopharmaceuticals Ltd
$604,584
Supply of Haemophilia A Treatment Products to NHS National Services ScotlandHealth & MedicalNovo Nordisk Ltd,Shire Pharmaceuticals Limited,Swedish Orphan Biovitrum Ltd
$4,100,000
Supply of Recombinant Factor XIII for Blood Disorders to NHS ScotlandHealth & MedicalNovo Nordisk Ltd
$129,113
Supply of Blood Disorder Treatments Including Haemophilia A & B to NHS ScotlandHealth & MedicalTakeda UK Limited,Octapharma Ltd,CSL Behring
$1,380,752
Supply of Blood Disorder Treatments to NHS ScotlandHealth & MedicalOctapharma Ltd,CSL Behring
$532,441
GovMarket
We do the hard work.
You win the work.
We find the tenders, read the documents and track who wins, so your time goes on bids you can win.
–open health and medical tenders right now
–new in the last 7 days
–contracts awarded in the last 12 months
7 days free, then £36/GBP per month
Revenue from government work£312K won so far





